Corbus Pharmaceuticals Holdings (CRBP) Total Debt (2013 - 2024)

Corbus Pharmaceuticals Holdings' Total Debt history runs 7 years deep, the most recent figure standing at $10.7 million for Q2 2024.

• In Q2 2024, Total Debt fell 5.39% year-over-year to $10.7 million; the TTM figure through Jun 2024 stood at $10.7 million (down 5.39% YoY), while the FY2023 annual figure was $15.9 million, down 15.09% from the prior year.
• Total Debt was $10.7 million for Q2 2024 at Corbus Pharmaceuticals Holdings, up from $10882.0 in the prior quarter.
• In the past five years, Total Debt ranged from a high of $19.3 million in Q3 2022 to a low of $10882.0 in Q1 2024.
• Historically, Total Debt has averaged $14.9 million across 5 years, with a median of $18.7 million in 2021.
• The sharpest annual moves came in 2022 and 2024: Total Debt gained 3.17% in 2022, then sank 99.94% in 2024.
• A 5-year view of Total Debt shows it stood at $18.8 million in 2020, then decreased by 0.51% to $18.7 million in 2021, then gained by 0.27% to $18.8 million in 2022, then fell by 15.09% to $15.9 million in 2023, then sank by 32.63% to $10.7 million in 2024.
• The last three Total Debt figures came in at $10.7 million (Q2 2024), $10882.0 (Q1 2024), and $15.9 million (Q4 2023), per Business Quant data.